Company / Operating Margin
IDEAYA Biosciences, Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-72.8%
FY2025
5-year range
-4671.1% / -72.8%
FY2021-FY2025
Trend
+98.4%
vs FY2024
Sector context
#80 of 135
Health Care
What the data says
At -72.8%, IDEAYA Biosciences, Inc.'s operating margin ranks #80 of 135 in the Health Care sector. Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -72.8%.
Based on SEC 10-K filings.
-72.8% in FY2025 with a 5-year CAGR of +113.5%.
Improved from -574.9% to -72.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +108.1pp
- 5-Year Change
- +113.5pp
- 10-Year Change
- -
Sector benchmark
#80 of 135 in Health CareTop 59% of 135This company -72.8% Sector average -774.4%
▼
+90.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 98.4% year-over-year.
- Currently 701.6pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -72.8% | +98.4% |
| FY2024 | -4671.1% | -712.6% |
| FY2023 | -574.9% | -217.8% |
| FY2022 | -180.9% | - |
| FY2021 | - | - |
| FY2020 | -186.4% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026